28 July 2016 by Mark Nicolls

Mark Nicholls - Rituximab for Scleroderma APAH

A presentation by Andrew Peacock at the 3rd Annual Drug Discovery & Development Symposium in Bethesda, Washington 11-12th July 2016.


Additional keywords: scleroderma,rituximab,ASCO,clinical trials,B cell

About the author

profile picture of Mark Nicolls

Mark Nicolls

Professor of Medicine, Chief of Pulmonary and Critical Care at Stanford

Stanford University

United States

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI